These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26374952)

  • 1. Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone.
    Canivet C; Menasria R; Rhéaume C; Piret J; Boivin G
    Antiviral Res; 2015 Nov; 123():105-13. PubMed ID: 26374952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis.
    Boivin N; Menasria R; Piret J; Rivest S; Boivin G
    Antiviral Res; 2013 Dec; 100(3):649-53. PubMed ID: 24416771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.
    Gnann JW; Sköldenberg B; Hart J; Aurelius E; Schliamser S; Studahl M; Eriksson BM; Hanley D; Aoki F; Jackson AC; Griffiths P; Miedzinski L; Hanfelt-Goade D; Hinthorn D; Ahlm C; Aksamit A; Cruz-Flores S; Dale I; Cloud G; Jester P; Whitley RJ;
    Clin Infect Dis; 2015 Sep; 61(5):683-91. PubMed ID: 25956891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
    Field HJ; Tewari D; Sutton D; Thackray AM
    Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir for herpes simplex encephalitis.
    Pouplin T; Pouplin JN; Van Toi P; Lindegardh N; Rogier van Doorn H; Hien TT; Farrar J; Török ME; Chau TT
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3624-6. PubMed ID: 21576427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis.
    Uyar O; Plante PL; Piret J; Venable MC; Carbonneau J; Corbeil J; Boivin G
    Sci Rep; 2021 Sep; 11(1):18688. PubMed ID: 34548521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis.
    Boivin N; Menasria R; Piret J; Boivin G
    Antiviral Res; 2012 Dec; 96(3):414-21. PubMed ID: 23043942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
    Wutzler P; Ulbricht A; Färber I
    Intervirology; 1997; 40(1):15-21. PubMed ID: 9268766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial Commentary: Failure of Adjunctive Valacyclovir to Improve Outcomes in Herpes Simplex Encephalitis.
    Tyler KL
    Clin Infect Dis; 2015 Sep; 61(5):692-4. PubMed ID: 25956893
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis.
    Thompson KA; Blessing WW; Wesselingh SL
    J Neurovirol; 2000 Feb; 6(1):25-32. PubMed ID: 10786994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
    Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
    Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.
    Zhou Y; Lu ZN; Guo YJ; Mei YW
    Neurol Res; 2010 Oct; 32(8):801-9. PubMed ID: 20483026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
    Tyler KL
    Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes encephalitis during natalizumab treatment in multiple sclerosis.
    Kwiatkowski A; Gallois J; Bilbault N; Calais G; Mackowiak A; Hautecoeur P
    Mult Scler; 2012 Jun; 18(6):909-11. PubMed ID: 22048950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia Activate Early Antiviral Responses upon Herpes Simplex Virus 1 Entry into the Brain to Counteract Development of Encephalitis-Like Disease in Mice.
    Katzilieris-Petras G; Lai X; Rashidi AS; Verjans GMGM; Reinert LS; Paludan SR
    J Virol; 2022 Mar; 96(6):e0131121. PubMed ID: 35045263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.